Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate

被引:8
|
作者
Lim, Bumjin [1 ]
Kim, Hong Bae [2 ]
Jeong, Seung [2 ]
Kim, Song Hee [3 ]
Kang, Jeon Min [3 ]
Park, Yubeen [3 ]
Won, Dong-Sung [3 ]
Kim, Ji Won [3 ]
Ryu, Dae Sung [3 ]
Kim, Yunlim [1 ]
Park, Jung-Hoon [3 ]
Kim, Choung-Soo [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Urol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 08826, South Korea
[3] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
RADICAL PROSTATECTOMY; ABLATION;
D O I
10.1038/s41598-021-96734-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The exposure of the prostate to high electric field strength during irreversible electroporation (IRE) has been extensively investigated. Multiple monopolar electrodes, however, have risks of organ piercing and bleeding when placing electrodes. A novel bipolar electrode made of pure platinum and stainless steel was developed for prostate cancer ablation. Voltages of 500 and 700 V were applied to the beagle prostate with this electrode to evaluate ablated tissues and their characteristics. IRE procedures were technically successful in all dogs without procedure-related complications. The current that flowed through the anode and cathode while applying 500 and 700 V were 1.75 +/- 0.25 A and 2.22 +/- 0.35 A, respectively. TUNEL assays showed that the estimated ablated areas when applying 500 and 700 V were 0.78 cm(2) and 1.21 cm(2), respectively. The minimum electric field strength threshold required for induction of IRE was 800 V/cm. The platinum electrode was resistant to corrosion. The IRE procedure for beagle prostates using a single bipolar electrode was technically feasible and safe. The novel bipolar electrode has great potential for treating human prostate cancer with fewer IRE-related complications.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Oncological and incontinence outcomes after focal irreversible electroporation of prostate cancer
    Yaxley, W. J.
    Gianduzzo, T.
    Kua, B.
    Oxford, R.
    Yaxley, J. W.
    BJU INTERNATIONAL, 2021, 128 : 38 - 39
  • [42] Irreversible electroporation. Current value for focal treatment of prostate cancer
    Wendler, J. J.
    Ganzer, R.
    Hadaschik, B.
    Blana, A.
    Henkel, T.
    Koehrmann, K. U.
    Machtens, S.
    Roosen, A.
    Salomon, G.
    Sentker, L.
    Witzsch, U.
    Schlemmer, H. P.
    Baumunk, D.
    Koellermann, J.
    Schostak, M.
    Liehr, U. B.
    UROLOGE, 2015, 54 (06): : 854 - 862
  • [43] Irreversible Electroporation (IRE) for Prostate Cancer (PCa) Treatment: The State of the Art
    Faiella, Eliodoro
    Santucci, Domiziana
    Vertulli, Daniele
    Vergantino, Elva
    Vaccarino, Federica
    Perillo, Gloria
    Zobel, Bruno Beomonte
    Grasso, Rosario Francesco
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (02):
  • [44] Prostate Cancer Recurrence and Persistence After Irreversible Electroporation Focal Ablation
    Isharwal, Sumit
    Greene, Kirsten L.
    JAMA SURGERY, 2023, 158 (04) : 349 - 349
  • [45] Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE)
    Blazevski, Alexandar
    Amin, Amer
    Scheltema, Matthijs J.
    Balakrishnan, Anjali
    Haynes, Anne-Maree
    Barreto, Daniela
    Cusick, Thomas
    Thompson, James
    Stricker, Phillip D.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (04) : 1107 - 1114
  • [46] Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study
    Yaxley, William John
    Gianduzzo, Troy
    Kua, Boon
    Oxford, Rachel
    Yaxley, John William
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (03) : 285 - 293
  • [47] A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer
    Xia, Zhi-Yu
    Yang, Jun
    Xiao, Fan
    Xu, Jin-Zhou
    Zhong, Xing-Yu
    Wang, Shao-Gang
    Xia, Qi-Dong
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [48] Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
    Naldi, Ilaria
    Taranta, Monia
    Gherardini, Lisa
    Pelosi, Gualtiero
    Viglione, Federica
    Grimaldi, Settimio
    Pani, Luca
    Cinti, Caterina
    PLOS ONE, 2014, 9 (05):
  • [49] Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study COMMENT
    Ahmed, Hashim
    Emberton, Mark
    JOURNAL OF UROLOGY, 2016, 196 (02): : 559 - 559
  • [50] Effects of different applied voltages of irreversible electroporation on prostate cancer in a mouse model
    Kim, Hong Bae
    Zeng, Chu Hui
    Kim, Yunlim
    Jeong, Seung
    Kim, Song Hee
    Kang, Jeon Min
    Park, Yubeen
    Won, Dong-Sung
    Kim, Ji Won
    Ryu, Dae Sung
    Lim, Bumjin
    Park, Jung-Hoon
    SCIENTIFIC REPORTS, 2022, 12 (01)